Oura Files a $2.2B IPO — But Most of the Money Goes Elsewhere
Oura, the Finnish health-tracking ring maker, publicly filed for its initial public offering, targeting up to $2.2 billion by pricing 50 million shares between $40 and $44 each. The company is applying to list on a major U.S. exchange. Revenue for the nine months ending June 30 hit $1.2 billion, up from $697 million in the same period a year earlier. Ring sales more than doubled, from 1.8 million units to 4.1 million over the same stretch.
That's the headline Oura wanted. Here's the part that got buried under the growth numbers:
What's not in dispute: Oura is growing fast, the filing is real, and 50 million shares are going to market.
What is in dispute: whether ordinary investors buying in at IPO are actually the intended beneficiaries of this deal.
On one side, the bull case is straightforward. Oura's subscription business carries an 89% gross margin. Paid membership more than doubled to $240.5 million in the period and now accounts for roughly 20% of total sales, with hardware pulling in $974 million on top of that. The company projects it will close its fiscal year with around 5.7 million paying members — nearly double the figure from a year ago. A market cap potentially reaching $14.1 billion at the top of the price range reflects a company that has found a recurring-revenue engine inside a hardware business, which is genuinely hard to do. Investors who believe wearables are eating the health-data market have a real story to buy.
On the other, the structure of this deal is unusual enough to stop you cold. Of the 50 million shares on offer, existing shareholders are selling 36.5 million — almost two-thirds of the total. At the $42 midpoint, that translates to roughly $1.53 billion flowing to those sellers versus about $567 million going to Oura itself. The single biggest beneficiary is Forerunner Ventures, the company's second-largest shareholder, which is selling its entire 9.3% stake — about 28.7 million shares — for approximately $1.2 billion before fees. Forerunner's shares alone represent nearly 80% of everything existing shareholders are offloading. And of the $532.6 million Oura itself expects to net, roughly $526.4 million is earmarked to cover tax obligations tied to employee share grants vesting at IPO. That leaves the company with an estimated $6.2 million for general corporate purposes. Not a typo.
The company is also carrying a net loss of $924 million for those nine months, even as revenue surged. And it held about $372 million in cash at the end of June — cash it is deliberately not touching to cover those tax bills.
Which leaves the question that actually matters, and the one the prospectus cannot answer for you:
When a company uses its IPO almost entirely to hand early backers an exit and settle internal tax obligations — is that a sign of financial discipline and confidence, or is it a structure that puts new public shareholders last in line before the party even starts?
The Arena models have a strong read on this one, and they don't agree. Watch below.
Does Oura's IPO primarily benefit existing shareholders cashing out rather than creating value for long-term public investors?
Listen to the full debate ►You can't simultaneously argue the company is thriving on its own cash generation — roughly $262 million in free cash flow last year — and that public investors are getting in on the ground floor of something that genuinely needs their capital to reach its potential.